Page last updated: 2024-11-06
carane
Description
Carane is a bicyclic monoterpene hydrocarbon found in various essential oils, particularly those from coniferous trees like pine, spruce, and fir. It is a colorless liquid with a characteristic terpene odor. Carane is synthesized through various pathways, including the isomerization of limonene and the reaction of α-pinene with hydrogen chloride. Carane exhibits antifungal and antibacterial properties and is also known to have potential anti-inflammatory effects. The presence of carane in essential oils contributes to their therapeutic benefits, particularly in aromatherapy. The study of carane is driven by its potential applications in medicine, cosmetics, and the fragrance industry. Carane's biological activity and its role in the composition of essential oils make it a subject of ongoing research.'
carane: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
carane : A carbobicyclic compound that is bicyclo[4.1.0]heptane substituted by methyl groups at positions 3, 7 and 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 79043 |
| CHEBI ID | 35663 |
| MeSH ID | M0095765 |
Synonyms (13)
| Synonym |
|---|
| bicyclo(4.1.0)heptane, 3,7,7-trimethyl- |
| ai3-28960 |
| carane |
| bicyclo[4.1.0]heptane, 3,7,7-trimethyl- |
| 3,7,7-trimethylbicyclo[4.1.0]heptane |
| CHEBI:35663 |
| 554-59-6 |
| (-)-cis-carane |
| BWRHOYDPVJPXMF-UHFFFAOYSA-N |
| bicyclo[4.1.0]heptane, 3,7,7-trimethyl-, [1s-(1.alpha.,3.alpha.,6.alpha.)]- |
| 3,7,7-trimethylbicyclo[4.1.0]heptane # |
| DTXSID10858852 |
| Q27116560 |
Drug Classes (3)
| Class | Description |
|---|
| terpenoid fundamental parent | |
| monoterpene | A C10 terpene. |
| carbobicyclic compound | A bicyclic compound in which all the ring atoms are carbon. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 57.64
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 57.64 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.59 (4.65) | | Search Engine Demand Index | 87.39 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |